Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Nea Ojala

1PUBLICATIONS

12CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Feb 05, 2025

The oncolytic adenovirus TILT-123 with pembrolizumab in platinum resistant or refractory ovarian cancer: the phase 1a PROTA trial.

Matthew Stephen Block, James Hugo Armstrong Clubb, Johanna Mäenpää

Pageof 1

Frequent Collaborators

1 joint publications

Matthew Stephen Block

1 joint publications

Santeri Pakola

1 joint publications

Elise Jirovec

1 joint publications

Lyna Haybout

1 joint publications

Teijo Pellinen

1 joint publications

Katja Välimäki

1 joint publications

Tuomo Alanko

1 joint publications

Daniel Adamo

1 joint publications

Jorma Sormunen

1 joint publications

Michael Jon Chisamore

Frequent Collaborators

1 joint publications

Matthew Stephen Block

1 joint publications

Santeri Pakola

1 joint publications

Elise Jirovec

1 joint publications

Lyna Haybout

Top Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

See more related videos

Top Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

See more related videos